Dario T.
- Country
- Italy
- Department
- NA
Research Overview
- Efficacy and Safety of Zenagamtide in Participants with Overweight or Obesity and Knee Osteoarthritis
- Efficacy and Safety of Zenagamtide (NNC0487-0111) in Participants with Overweight or Obesity and Knee Osteoarthritis
- Phase III Randomized, Double‑Blind, Placebo‑Controlled Study of Elecoglipron in Adults with Obesity or Overweight, With or Without Type 2 Diabetes Mellitus
Data & Insights
Has run more than one trial at 260 of 795 partner sites.
Specializations
Weight Management
Focused on investigating therapeutic approaches for obesity and overweight conditions, with particular emphasis on evaluating novel treatments in combination with lifestyle modifications.
- Weight reduction interventions
- Caloric restriction protocols
- Physical activity integration
Explores the efficacy of weight management medications as adjunct therapies to lifestyle changes.
Cardiovascular Health
Specializes in heart failure prevention and cardiovascular risk management, with particular focus on innovative combination therapies for high-risk patients.
- Heart failure prevention strategies
- Cardiovascular mortality reduction
- Combination therapy approaches
Investigates novel therapeutic combinations for optimizing cardiovascular outcomes.
Cardiometabolic Research
Concentrates on the intersection of metabolic disorders and cardiovascular safety, particularly in patients with obesity.
- Cardiovascular safety assessment
- Major adverse cardiac events
- Coronary revascularization outcomes
Evaluates long-term cardiovascular implications of obesity treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.